OraSure Technologies Company Profile (NASDAQ:OSUR)

Analyst Ratings

Consensus Ratings for OraSure Technologies (NASDAQ:OSUR) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $8.20 (26.93% upside)

Analysts' Ratings History for OraSure Technologies (NASDAQ:OSUR)
Show:
DateFirmActionRatingPrice TargetActions
7/5/2016BTIG ResearchReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/5/2016MizuhoReiterated RatingOutperform$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Raymond James Financial Inc.DowngradeOutperform -> Market Perform$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016Canaccord GenuityReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Jefferies GroupLower Price TargetBuy$9.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015JMP SecuritiesDowngradeOutperform -> Market Perform$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for OraSure Technologies (NASDAQ:OSUR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2016Q1$0.02$0.04$28.82 million$29.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2016Q4$0.03$0.08$29.73 million$32.38 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.01)$0.03$29.58 million$29.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215$0.01$0.03$28.95 million$30.34 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2015Q414($0.04)($0.05)$28.22 million$28.68 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314($0.05)$0.02$27.20 million$27.85 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214($0.04)$0.04$26.21 million$26.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.13)($0.10)$23.28 million$23.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2014Q413($0.08)$0.11$27.43 million$28.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2013Q313($0.10)($0.03)$24.21 million$24.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.16)($0.10)$23.67 million$24.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q1 2013($0.18)($0.18)$20.82 million$21.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2013Q4 2012($0.14)($0.11)$20.87 million$22.14 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.07)($0.04)$22.26 million$22.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012($0.08)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012($0.09)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2011($0.07)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2011($0.05)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011($0.08)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2011($0.08)($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for OraSure Technologies (NASDAQ:OSUR)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.02)$0.01($0.01)
Q2 20161$0.03$0.03$0.03
Q3 20162$0.03$0.04$0.04
(Data provided by Zacks Investment Research)

Dividends

Dividend History for OraSure Technologies (NASDAQ:OSUR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OraSure Technologies (NASDAQ:OSUR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/19/2014Ronald H SpairCFOSell75,974$10.01$760,499.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Ronald H SpairCFOSell1,026$10.00$10,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014Ronald H SpairCFOSell126$10.00$1,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for OraSure Technologies (NASDAQ:OSUR)
DateHeadline
07/22/16 08:39 AMOraSure Technologies, Inc. (NASDAQ:OSUR): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 08:39 AMAccounts Payable For OraSure Technologies, Inc. (NASDAQ:OSUR) Stood At $5.287 - RealistInvestor.com
07/19/16 06:41 AMShares Lower on the Year OraSure Technologies, Inc. (NASDAQ:OSUR) - Press Telegraph
07/17/16 09:53 AMNext Weeks Broker Price Targets For OraSure Technologies, Inc. (NASDAQ:OSUR) - Fiscal Standard
07/17/16 09:53 AMStrong Sell Calls For OraSure Technologies, Inc. (NASDAQ:OSUR) At 0 - Investor Newswire
07/15/16 10:41 AMAnalyst Target and Average Rating Watch: OraSure Technologies, Inc. (NASDAQ:OSUR) - Press Telegraph
07/13/16 08:38 AMWere Analysts Bullish OraSure Technologies, Inc. (NASDAQ:OSUR) This Week? - Consumer Eagle
07/13/16 08:10 AMCoverage Initiated on Select Healthcare Stocks -
07/13/16 05:13 AMOraSure Technologies Earnings Conference Call Invitation - [at noodls] - BETHLEHEM, Pa., July 13, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 second quarter financial results, 2016 third ...
07/12/16 10:00 AMRecent Analysts Moves of Stocks: OraSure Technologies, Inc. (NASDAQ:OSUR) , Molina Healthcare Inc (NYSE:MOH) - Street Updates
07/08/16 05:42 PMCan OraSure Technologies, Inc. (NASDAQ:OSUR) Improve on the Earnings Front? - Engelwood Daily
07/08/16 05:42 PMCompany Stock Focus for OraSure Technologies, Inc. (NASDAQ:OSUR): Which Way Will Shares Head? - Press Telegraph
07/08/16 05:42 PMBroker Outlook For OraSure Technologies, Inc. (NASDAQ:OSUR) - Fiscal Standard
07/07/16 05:43 PMOraSure Technologies (OSUR) : Analyst Rating Update - Trade Calls
07/07/16 05:43 PMOraSure Technologies Inc. (OSUR) Jumps 5.03% on July 06 - Equities.com
07/05/16 05:28 PMPerformance watch list: OraSure Technologies, Inc. (NASDAQ:OSUR) - News Oracle
07/05/16 10:09 AMInvestors Are Watching: OraSure Technologies, Inc. (NASDAQ:OSUR), Intricon (NASDAQ:IIN), Steel Dynamics Inc ... - KC Register
07/05/16 10:09 AMOraSure Technologies, Inc. (NASDAQ:OSUR) & Chubb Ltd (NYSE:CB) Stocks Trending Alert - Money News (press release)
07/05/16 06:00 AMRecro Pharma Appoints Michael Celano as Chief Financial Officer - [GlobeNewswire] - MALVERN, Pa., July 05, 2016-- Recro Pharma, Inc., a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of pain, today announced the appointment ...
07/04/16 10:22 AMStock Valuation in Review: OraSure Technologies, Inc. (NASDAQ:OSUR) - Telanagana Press
07/04/16 10:22 AMSales of $136.196 expected for OraSure Technologies, Inc. (NASDAQ:OSUR) - Investor Newswire
07/01/16 05:43 PMTracking Stock Volatility for: OraSure Technologies, Inc. (NASDAQ:OSUR) - Engelwood Daily
07/01/16 05:43 PMOraSure Technologies Investor Call Invitation - GlobeNewswire (press release)
07/01/16 05:43 PMOraSure Technologies, Inc. (NASDAQ:OSUR) & Transition Therapeutics Inc (USA) (NASDAQ:TTHI) Traders Recap - Money News (press release)
07/01/16 05:43 PMOraSure Technologies Inc. (OSUR) Drops 16.53% on June 30 - Equities.com
07/01/16 08:28 AMOrasure Technologies ends HCV marketing deal with AbbVie
07/01/16 07:37 AMORASURE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material De -
07/01/16 07:34 AMOraSure's stock drops after co-promotion pact with AbbVie ends early -
07/01/16 07:30 AMOraSure Technologies Inc HCV Business Update Call scheduled for 8:30 am ET today -
07/01/16 05:21 AMOraSure Technologies and AbbVie Agree to an Early Termination of HCV Co-Promotion Agreement - [at noodls] - BETHLEHEM, Pa., July 01, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies (NASDAQ:OSUR), a market leader in point of care diagnostics, announced today that OraSure Technologies and AbbVie have mutually agreed ...
07/01/16 05:05 AM6:05 am OraSure and AbbVie (ABBV) terminate their master program services and co-promotion agreement for the OraQuick HCV Rapid Antibody Test in the US -
06/30/16 05:57 PMUpdate on Stock Volatility for: OraSure Technologies, Inc. (NASDAQ:OSUR) - Engelwood Daily
06/30/16 05:57 PMTrending Stock Analysis: OraSure Technologies, Inc. (NASDAQ:OSUR) - News Oracle
06/30/16 04:00 PMOraSure Technologies Investor Call Invitation - [GlobeNewswire] - Investor Conference Call July 1, 2016, 8:30 a.m. ET. BETHLEHEM, Pa., June 30, 2016-- OraSure Technologies, Inc. has scheduled an investor conference call and simultaneous webcast for 8:30 a.m. ET on July ...
06/29/16 08:31 AMOraSure Technologies, Inc. (NASDAQ:OSUR) Company Rating and Target Watch - Telanagana Press
06/28/16 10:34 AMOraSure Technologies, Inc. (NASDAQ:OSUR) Yearly Sales Target At $136.196 - Investor Newswire
06/28/16 10:34 AMShare Update and Earnings Review for OraSure Technologies, Inc. (NASDAQ:OSUR) - Press Telegraph
06/25/16 05:09 PMStrong Sell Calls Recommendations For OraSure Technologies, Inc. (NASDAQ:OSUR) At 0 - Investor Newswire
06/25/16 05:09 PMOraSure Technologies, Inc. (NASDAQ:OSUR) Low Price Is Set At $8.5 - RealistInvestor.com
06/24/16 05:42 PMCovering the Bases on OraSure Technologies, Inc. (NASDAQ:OSUR): Where is the Stock Going? - Press Telegraph
06/24/16 05:42 PMOraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Glance and Target Price Review - Engelwood Daily
06/21/16 05:13 PMVolatile post-earnings mover: OraSure Technologies, Inc. (NASDAQ:OSUR) - iStreetWire
06/20/16 07:18 AMOraSure Technologies, Inc. (NASDAQ:OSUR) Yearly Sales Projections At $136.196 - Investor Newswire
06/20/16 07:18 AMOraSure Technologies, Inc. (NASDAQ:OSUR) Analyst Price Targets For The Coming Week - Fiscal Standard
06/19/16 09:36 AMStrong Buy Calls Count For OraSure Technologies, Inc. (NASDAQ:OSUR) At 1 - Investor Newswire
06/18/16 04:56 PMOraSure Technologies (NASDAQ:OSUR) target price maintained to $0 as announced today by Raymond James - Breaking Finance News
06/18/16 09:51 AMWhat Analyst’s have to say about OraSure Technologies (NASDAQ:OSUR)?
06/17/16 11:14 AMOraSure Technologies, Inc. – Value Analysis (NASDAQ:OSUR) : June 17, 2016 -
06/15/16 05:40 PMOraSure Technologies Inc. (OSUR) is Trading Lower on Unusual Volume for June 13 - Equities.com
06/14/16 05:27 PMAnalyst Recommendations on These Stocks: OraSure Technologies, Inc. (NASDAQ:OSUR), Twenty-First Century Fox ... - Beacon Chronicle

Social

About OraSure Technologies

OraSure Technologies logoOraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. Its diagnostic products include tests, such as OraQuick Rapid HIV Test, OraQuick In-Home HIV Test, OraQuick HIV Self-Test, OraQuick HCV Rapid Antibody Test, OraQuick Ebola Rapid Antigen Test, OraSure QuickFlu Rapid Flu A&B Test, OraSure Collection Device, Molecular Collection Systems, Cryosurgical Systems (Skin Lesion Removal Products), Immunoassay Tests and Reagents, Western blot HIV-1 Confirmatory Test and Q.E.D. Saliva Alcohol Test. Its products are sold in the United States and internationally to clinical laboratories and hospitals.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: OSUR
  • CUSIP: 68554V10
Key Metrics:
  • Previous Close: $6.49
  • 50 Day Moving Average: $6.80
  • 200 Day Moving Average: $6.71
  • P/E Ratio: 36.29
  • P/E Growth: 1.25
  • Market Cap: $358.42M
  • Beta: 1.32
  • Current Year EPS Consensus Estimate: $0.23 EPS
  • Next Year EPS Consensus Estimate: $0.14 EPS
Additional Links:
OraSure Technologies (NASDAQ:OSUR) Chart for Saturday, July, 23, 2016